Publications by authors named "Said Saim"

Claim this Profile
E
Extended Intraocular Drug-Delivery Platforms for the Treatment of Retinal and Choroidal Diseases.
Charles C Wykoff, Baruch D Kuppermann, Carl D Regillo, Margaret Chang, Seenu M Hariprasad

J Vitreoretin Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorolanib, sunitinib, and axitinib: A comparative study of vascular endothelial growth factor receptor inhibitors and their anti-angiogenic effects.
Sophie J Bakri, Jeff Lynch, Michelle Howard-Sparks, Stephan Saint-Juste, Said Saim

PLoS One· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Crudele et al. Commentary on Mayock et al. "In Vitro Drug Release after Crushing: Evaluation of Xtampza ER and Other ER Opioid Formulations".
Alison B Fleming, Stephen P Mayock, Said Saim

Clin Drug Investig· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Drug Release After Crushing: Evaluation of Xtampza ER and Other ER Opioid Formulations.
Stephen P Mayock, Said Saim, Alison B Fleming

Clin Drug Investig· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction to: In Vitro Drug Release After Crushing: Evaluation of Xtampza ER and Other ER Opioid Formulations.
Stephen P Mayock, Said Saim, Alison B Fleming

Clin Drug Investig· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD).
Alison B Fleming, Douglas R Carlson, Ravi K Varanasi, Michael Grima, Stephen P Mayock, Said Saim

Pain Pract· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation.
Ernest A Kopecky, Alison B Fleming, Patrick K Noonan, Ravi K Varanasi, Michael Grima, Said Saim

J Opioid Manag· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process for overcoming drug retention in hard gelatin inhalation capsules.
Said Saim, Stephen T Horhota

Drug Dev Ind Pharm· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis